tiprankstipranks
Trending News
More News >
Marcus Corp. (MCS)
NYSE:MCS

Marcus (MCS) AI Stock Analysis

Compare
312 Followers

Top Page

MCS

Marcus

(NYSE:MCS)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
$17.50
▲(11.04% Upside)
Action:ReiteratedDate:02/27/26
The score is driven primarily by improving financial performance (strong revenue rebound and better leverage) but constrained by thin margins and weak free-cash-flow generation. Technicals are supportive with the stock trading above major moving averages and moderately positive momentum. Valuation is the key negative due to the very high P/E, while the earnings call adds a modest positive from lower 2026 capex/free-cash-flow outlook tempered by attendance and EBITDA/cash-flow pressures.
Positive Factors
Strong Revenue Momentum
A large TTM revenue increase (+68.8%) and return to positive net income reflect durable demand recovery and effective pricing. Sustained top-line momentum improves operating leverage potential, funds reinvestment and shareholder returns, and provides a structural base for further margin improvement if execution holds.
Improved Capital Structure
Material deleveraging versus prior years (debt-to-equity ~0.75–0.80) and stable equity provide greater financial flexibility. A healthier balance sheet reduces refinancing risk, supports opportunistic buybacks or M&A, and increases resilience to cyclical shocks in the hotel and theater businesses over the medium term.
CapEx Reduction to Raise Free Cash Flow
Management's planned capex cut from prior-year levels should materially lift free cash flow, enabling sustained dividends, opportunistic repurchases and selective reinvestment. Lower recurring capex improves cash conversion dynamics and creates a lasting lever to fund growth or return capital if trends persist.
Negative Factors
Very Thin Profitability
With net margins around 0.7% and TTM ROE low, the business has minimal earnings cushion. The anomalous >100% TTM gross margin suggests distortions or one-offs, making underlying profitability hard to trust and leaving limited ability to absorb revenue shocks or fund strategic reinvestment from current profits.
Weak Free Cash Flow Conversion
Despite solid operating cash flow (~$84M TTM), free cash flow is essentially breakeven and down sharply, indicating reinvestment, working capital swings or inefficiency. Persistent weak FCF limits capacity to reduce debt, sustain buybacks or absorb cyclical downturns without cutting investment or returns.
Industry Sensitivity and Operating Pressure
Theatre results show exposure to film-slate variability and attendance declines; hotels face occupancy and booking pace uncertainty. These structural sensitivities have driven lower adjusted EBITDA and falling operating cash flow, making earnings and cash generation fragile in adverse industry cycles.

Marcus (MCS) vs. SPDR S&P 500 ETF (SPY)

Marcus Business Overview & Revenue Model

Company DescriptionThe Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. It operates in two segments, Theatres, and Hotels and Resorts. The Theatres segment operates multiscreen motion picture theatres, as well as Funset Boulevard, a family entertainment center. The Hotels and Resorts segment owns and operates full-service hotels and resorts, as well as manages full-service hotels, resorts, and other properties. The company also provides hospitality management services, including check-in, housekeeping, and maintenance for a vacation ownership development. As of December 30, 2021, it owned or operated 1,064 screens at 85 movie theatre locations in 17 states under the Marcus Theatres, Movie Tavern by Marcus, and BistroPlex brands; and operated 8 wholly-owned or majority-owned hotels and resorts, as well as managed 11 hotels, resorts, and other properties for third parties. The company was founded in 1935 and is headquartered in Milwaukee, Wisconsin.
How the Company Makes MoneyMarcus generates revenue primarily through interest income from personal loans and savings accounts. The company attracts deposits from customers by offering competitive interest rates, which allows them to use these funds for lending at higher rates. Additionally, Marcus earns fees from various financial products and services, such as loan origination fees and investment management fees. Partnerships with financial technology companies and integrations with digital platforms also contribute to its revenue by expanding its customer base and enhancing its service offerings.

Marcus Earnings Call Summary

Earnings Call Date:Feb 26, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 30, 2026
Earnings Call Sentiment Neutral
The call presented a mixed but stable picture: the company delivered a strong fourth quarter with both divisions outperforming industry peers and demonstrated meaningful per-cap and pricing gains, record hotel results, and a clear plan to reduce 2026 capex to boost free cash flow and return capital to shareholders. Offsetting these positives were full-year declines in adjusted EBITDA and operating income, a notable drop in cash flow from operations year-over-year, attendance declines in theaters, a Q4 impairment charge, and industry-wide variability tied to film supply and blockbuster performance. Management emphasized operational improvements, technology and loyalty initiatives, and disciplined capital allocation while acknowledging near-term headwinds and the one-time nature of some items.
Q4-2025 Updates
Positive Updates
Consolidated Quarterly Revenue Growth
Consolidated revenues for Q4 fiscal 2025 were $193,500,000, a 2.8% increase compared to the prior-year quarter, with revenue growth in both theater and hotel divisions.
Consolidated Adjusted EBITDA and Q4 Operating Income
Consolidated adjusted EBITDA for Q4 was $26,800,000, up 3.6% year-over-year. Excluding a $5.2M theater impairment charge, Q4 operating income was $6,900,000, up 5.2% versus adjusted operating income in the prior-year quarter.
Theater Division Outperformance and Pricing Gains
Theater total revenue in Q4 was $123,800,000, up 2.2%. On a comparable fiscal-week basis, comparable theater admission revenue (calendar basis) increased 6.1%. Average admission price increased 12.7%, and the company outperformed U.S. box office receipts by approximately 7.6 percentage points during the quarter (U.S. box office receipts decreased 1.5%).
Concession and F&B Per-Cap Growth & Digital Initiatives
Per-cap concession, food and beverage revenues increased 7.2% in the quarter driven by higher incidence, merchandising, pricing, and favorable film mix. The company rolled out queuing improvements, new digital ticketing, QR code ordering tests, and tap-pay terminals to boost per-cap and digital sales.
Hotels: Record Year, RevPAR and ADR Growth
Hotels delivered a record revenue and adjusted EBITDA year for fiscal 2025. For Q4, RevPAR for owned hotels grew 3.5% and average daily rate (ADR) grew 5.6% year-over-year. Q4 hotels adjusted EBITDA was $7,300,000, up 3.4%, and the hotels outperformed comparable upper-upscale RevPAR by 2.7 percentage points and local competitive sets by 5.5 percentage points.
Capital Return to Shareholders
Share repurchases totaled ~118,000 shares in Q4 for $1.8M and just over 1,100,000 shares (~3.6% of outstanding shares) for ~ $18M in fiscal 2025. Cumulative buybacks since resuming in 3Q 2024 are over 1,800,000 shares (~5.7%) returning nearly $28M; combined with dividends, the company has returned over $45M to shareholders in the last two years.
Lower Planned CapEx and Free Cash Flow Outlook for 2026
Company expects total capital expenditures of $50M–$55M in fiscal 2026 (down from $83M in FY2025), with ~$25M–$30M for hotels and $20M–$25M for theaters, which management expects will materially increase free cash flow available for growth or shareholder returns.
Negative Updates
Attendance Declines Despite Revenue Gains
Comparable theater attendance decreased 5.7% in fiscal 2025 fourth quarter (and decreased 12.1% on a calendar quarter comparable basis). Management attributes revenue growth largely to price optimization and favorable film mix, not attendance gains.
Full-Year EBITDA and Operating Income Pressure
Full-year adjusted EBITDA decreased 3.1% to $99,300,000 for fiscal 2025. Consolidated operating income for the year was $17,100,000; excluding the Q4 theater impairment, full-year operating income was $22,200,000 compared to $25,900,000 in fiscal 2024 (a notable year-over-year decline).
Decline in Cash Flow from Operations
Cash flow from operations for Q4 FY2025 was $48,800,000 versus $52,600,000 in the prior-year quarter. On a full-year basis, cash flow from operations was $84,200,000 compared to just under $104,000,000 in fiscal 2024 — a substantial decrease driven by working capital timing and other factors.
Impairment Charges and One-Time Tax Items
The quarter included $5,200,000 of non-cash impairment charges in the theater division that reduced GAAP operating income (these are excluded from adjusted EBITDA). Separately, a $7,600,000 historic tax credit (approx. $0.24 per share) benefited net earnings but was a one-time, non-operational item excluded from adjusted EBITDA.
Industry Headwinds and Film Slate Variability
Management noted a softer overall industry box office for the year and the absence of a >$500M blockbuster in 2025, which limited upside; the company emphasized product-supply variability and that the year’s results were sensitive to one or two films not performing as hoped.
Hotel Occupancy and Booking/Pace Uncertainties
Owned hotel occupancy in Q4 was 60.2%, down 1.2 percentage points year-over-year. While hotels posted record results, management noted mixed leisure demand across markets, renovation-related disruptions (Hilton Milwaukee) earlier in the year, and that group pace for 2027 is slightly behind the comparable prior-year booking curve.
Company Guidance
Management guided fiscal 2026 total capital expenditures of $50.0–$55.0 million (down from $83.0M in FY2025), with roughly $25.0–$30.0M for hotels and $20.0–$25.0M for theaters, saying the CapEx decline should drive a significant increase in free cash flow and “very strong” free cash flow conversion to fund opportunistic growth investments and returns to shareholders (they plan to grow the quarterly dividend and continue opportunistic share repurchases). They reiterated a disciplined allocation approach, noted the theater segment historically contributes roughly 50% on contribution margin to EBITDA, said they remain “actively searching” for M&A while recognizing slow transaction markets, and reminded investors of recent capital returns (Q4 repurchases ~118k shares for $1.8M; ~1.1M shares repurchased in 2025, ~3.6% of outstanding, for ~$18M; cumulative buybacks since resuming in Q3 2024 >1.8M shares or ~5.7% for ~$28M; >$45M returned to shareholders over the last two years including dividends).

Marcus Financial Statement Overview

Summary
Improving fundamentals with sharply higher TTM revenue (+68.8%) and a return to positive net income, plus a healthier leverage profile (debt-to-equity ~0.75–0.80). Offsetting this, profitability remains very thin (~0.7% net margin) and free cash flow is near breakeven (~$1.0M) despite solid operating cash flow (~$84M). An unusually high reported TTM gross margin (>100%) reduces confidence in margin quality.
Income Statement
62
Positive
TTM (Trailing-Twelve-Months) revenue is up sharply (+68.8%), showing strong top-line momentum. Profitability has improved versus recent years with positive net income (about $12.7M) and positive operating profit, but net margins remain very thin (~0.7%), leaving limited cushion if attendance or pricing weakens. A notable watch-out is the unusually high TTM gross margin (>100%), which is inconsistent with the prior-year range (~39%) and suggests the TTM gross profit figure may be distorted—reducing confidence in margin quality.
Balance Sheet
66
Positive
Leverage has improved meaningfully since 2020–2021, with debt-to-equity now around ~0.75–0.80 versus >1.1 previously, indicating a healthier capital structure. Equity is stable (~$457M TTM) and the asset base is steady (~$1.0B). However, returns are still modest (TTM return on equity ~1.7%), reflecting low profitability, and total debt remains sizable (~$223M), which can pressure flexibility if cash flow weakens.
Cash Flow
54
Neutral
Operating cash flow remains solid in absolute dollars (TTM ~$84M), supporting ongoing operations. The main weakness is conversion to free cash flow: TTM free cash flow is near breakeven (~$1.0M) and down sharply (free cash flow growth -42.4%), implying heavier reinvestment or weaker cash efficiency. Free cash flow is also very small relative to earnings in the TTM period, which limits near-term financial flexibility despite positive operating cash generation.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue758.46M735.56M729.58M677.39M458.24M
Gross Profit777.95M327.84M286.54M257.39M183.74M
EBITDA90.37M68.72M101.67M80.41M31.84M
Net Income12.69M-7.79M14.79M-11.97M-43.29M
Balance Sheet
Total Assets1.01B1.04B1.07B1.06B1.19B
Cash, Cash Equivalents and Short-Term Investments23.45M48.98M60.95M25.64M22.27M
Total Debt335.48M352.63M379.06M407.77M515.10M
Total Liabilities557.15M579.66M593.93M607.68M734.75M
Stockholders Equity457.38M464.87M471.17M456.92M453.61M
Cash Flow
Free Cash Flow989.00K24.73M63.85M56.37M29.17M
Operating Cash Flow84.20M103.94M102.63M93.21M46.25M
Investing Cash Flow-71.37M-81.90M-36.75M-346.00K10.88M
Financing Cash Flow-30.82M-37.30M-30.55M-92.41M-47.17M

Marcus Technical Analysis

Technical Analysis Sentiment
Negative
Last Price15.76
Price Trends
50DMA
15.82
Negative
100DMA
15.42
Positive
200DMA
15.60
Positive
Market Momentum
MACD
0.03
Positive
RSI
43.51
Neutral
STOCH
4.81
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MCS, the sentiment is Negative. The current price of 15.76 is below the 20-day moving average (MA) of 16.42, below the 50-day MA of 15.82, and above the 200-day MA of 15.60, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 43.51 is Neutral, neither overbought nor oversold. The STOCH value of 4.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MCS.

Marcus Risk Analysis

Marcus disclosed 30 risk factors in its most recent earnings report. Marcus reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Marcus Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$2.11B56.8410.67%9.30%67.19%
61
Neutral
$3.09B19.4425.84%1.45%9.70%-31.62%
61
Neutral
$474.03M20.032.82%1.97%6.28%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
49
Neutral
$297.29M-1.889.18%-7.38%-483.59%
45
Neutral
$233.09M-19.80%-2.85%75.96%
44
Neutral
$571.91M35.45%9.74%12.29%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MCS
Marcus
15.76
-1.29
-7.57%
AMCX
AMC Networks
6.96
-0.20
-2.79%
CNK
Cinemark Holdings
26.76
0.97
3.76%
IMAX
IMAX
39.05
13.12
50.60%
AMC
AMC Entertainment
1.08
-1.96
-64.47%
STRZ
Starz Entertainment Corp
13.89
3.46
33.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 27, 2026